You are here

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2026

AbstractFullPdf
Jan 2020770
Feb 202040400
Mar 202042421
Apr 202034349
May 202029295
Jun 202051517
Jul 2020353518
Aug 202012112133
Sep 2020424222
Oct 2020454529
Nov 2020373715
Dec 2020343417
Jan 2021535335
Feb 2021868726
Mar 2021404018
Apr 2021424214
May 2021303017
Jun 2021303020
Jul 2021333327
Aug 2021272720
Sep 2021303015
Oct 2021383842
Nov 2021282730
Dec 2021383822
Jan 2022668543
Feb 2022414326
Mar 2022495123
Apr 2022657618
May 2022788137
Jun 2022808529
Jul 2022909322
Aug 2022737523
Sep 2022979934
Oct 2022808119
Nov 20227812327
Dec 2022676711
Jan 2023596121
Feb 2023505320
Mar 2023444411
Apr 2023474921
May 2023535423
Jun 2023636412
Jul 2023535427
Aug 2023757526
Sep 2023838739
Oct 2023717231
Nov 2023828222
Dec 2023878719
Jan 2024575722
Feb 20249710124
Mar 2024949648
Apr 2024878840
May 2024858827
Jun 2024878827
Jul 202410710822
Aug 2024898917
Sep 2024848627
Oct 202410410752
Nov 202413814143
Dec 202413713944
Jan 202512712933
Feb 202517617650
Mar 202511111336
Apr 202515515523
May 202511511830
Jun 202510010236
Mar 2026110
Total457447151627